-transparent.png){kind=logo}
Many reports have described low platelet monoamine oxidase (MAO) activity in chronic schizophrenia. In an effort to determine whether this low activity is genetically controlled, the authors studied platelet MAO activity in the first-degree relatives of 12 chronic schizophrenics (who themselves had low platelet MAO activity). The 29 relatives had significantly lower mean Vmax and Km values than a control group. The authors postulate that the low platelet MAO activity among chronic schizophrenics may be a genetic marker for vulnerability to chronic schizophrenia.
Related Publications
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
February 1975,
Nature,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
July 1975,
Psychopharmacology bulletin,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
November 1985,
Clinica chimica acta; international journal of clinical chemistry,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
November 1975,
National Institute on Drug Abuse research monograph series,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
January 1981,
Psychopharmacology bulletin,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
July 1977,
The American journal of psychiatry,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
June 1960,
Diseases of the nervous system,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
May 1981,
Clinical genetics,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
January 1978,
The American journal of psychiatry,
W H Berrettini, and
T C Benfield, and
A O Schmidt, and
R K Ladman, and
W H Vogel
July 1987,
The Indian journal of medical research,
